Todd Berard - Jan 18, 2023 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role: Chief Marketing Officer
Signature: /s/ Todd C.J. Berard
Stock symbol: BLFS
Transactions as of: Jan 18, 2023
Transactions value $: -$149,370
Form type: 4
Date filed: 1/20/2023, 06:23 PM
Previous filing: Jan 10, 2023
Next filing: Jan 25, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BLFS	Common Stock	Options Exercise	$13.4K	+6.5K	+5.45%	$2.06^*	126K	Jan 18, 2023	Direct
transaction	BLFS	Common Stock	Sale	-$163K	-6.5K	-5.17%	$25.04	119K	Jan 18, 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BLFS	Stock Option (Right to Buy)	Options Exercise	$0	-6.5K	-13%	$0.00	43.5K	Jan 18, 2023	Common Stock	6.5K	$2.06	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.10, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3	Exercisable to the extent of 1/4th thereof on 5/4/16, and remaining balance exercisable to the extent of 1/36th thereof on the 4th day of each month commencing on 6/4/16.